Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
Trial details
- Registry ID
- NCT07246590
- Phase
- Phase 3
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)NCT07246590 | VRCA | Phase 3 | Active not recruiting | 2026-11Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |